Gene: PI4K2A
Official Full Name: phosphatidylinositol 4-kinase type 2 alphaprovided by HGNC
Gene Summary: Phosphatidylinositolpolyphosphates (PtdInsPs) are centrally involved in many biologic processes, ranging from cell growth and organization of the actin cytoskeleton to endo- and exocytosis. PI4KII phosphorylates PtdIns at the D-4 position, an essential step in the biosynthesis of PtdInsPs (Barylko et al., 2001 [PubMed 11244087]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07939 | PI4K2A Knockout cell line (HeLa) | Human | PI4K2A | 1:3~1:6 | Negative | Online Inquiry |
KO07940 | PI4K2A Knockout cell line (HCT 116) | Human | PI4K2A | 1:2~1:4 | Negative | Online Inquiry |
KO07941 | PI4K2A Knockout cell line (HEK293) | Human | PI4K2A | 1:3~1:6 | Negative | Online Inquiry |
KO07942 | PI4K2A Knockout cell line (A549) | Human | PI4K2A | 1:3~1:4 | Negative | Online Inquiry |
PI4K2A Gene Knockout Cell Lines are engineered cellular models that have undergone targeted genetic modification to disrupt the expression of the phosphatidylinositol 4-kinase type 2 alpha (PI4K2A) gene. This gene is crucial for the synthesis of phosphatidylinositol 4-phosphate, a lipid that plays a pivotal role in membrane dynamics, intracellular signaling, and vesicular trafficking. The knockout of the PI4K2A gene results in a profound alteration of cellular processes, enabling researchers to study the implications of PI4K2A deficiency in various biological contexts.
Functionally, these knockout cell lines serve as invaluable tools to investigate the cellular signaling pathways that rely on PI4K2A, notably those involving cell growth, differentiation, and apoptosis. The underlying mechanism of action involves the examination of downstream effects attributable to the absence of PI4K2A, facilitating a deeper understanding of its role in diverse diseases, including cancers and neurodegenerative disorders.
The scientific significance of PI4K2A Gene Knockout Cell Lines lies in their potential to unveil novel therapeutic targets and biomolecular mechanisms. These models have applications in drug discovery, pharmacological testing, and the elucidation of disease mechanisms in both basic research and clinical settings. Compared to alternatives such as transient or stable overexpression systems, knockout models provide a more robust and physiologically relevant platform for understanding gene function and therapeutic intervention.
For researchers and clinicians, these cell lines represent a unique opportunity to explore critical signaling pathways with greater specificity and accuracy. The ability to manipulate PI4K2A provides insights that can lead to the development of targeted therapies and the identification of biomarkers for better disease management.
Our company specializes in producing high-quality genetic models tailored for advanced research, backed by a commitment to scientific excellence and innovation. By choosing our PI4K2A Gene Knockout Cell Lines, you gain access to a meticulously engineered resource that enhances your research capabilities and contributes to the advancement of biomedical knowledge.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.